Loading content
Professor Colin Green

Professor Colin Green

Professor of Health Economics

2283

South Cloisters 1.07

Colin Green is Professor of Health Economics, based in the University of Exeter Medical School, University of Exeter, UK.  He leads health economics across the Medical School, and is Head of the Health Economics Group.

Research interests and activities involve the application of economic principles in a health and healthcare setting, with the aim being to improve health and related decision making and to improve people lives.  Research to date covers applied and methodological research, across a wide range of settings and health contexts.  

Research includes the economic evaluation of health technologies, modeling of cost-effectiveness analyses, assessment and valuation of health outcomes, and research in the area of social values/priority-setting. Particular interest areas are multiple sclerosis, dementia and Alzheimer’s disease, and neurodegenerative conditions more broadly.

Prior roles and research have supported the UK NICE health technology appraisal process (e.g. assessment of drugs for renal cancer, drugs for Alzheimer’s disease), and work to date has involved supporting a number of research funding committees, for the NIHR and for Charities. Colin serves on the editorial board for Applied Health Economics & Health Policy, is an Academic Editor for PLOS ONE, and he supports regional NHS Partners.  

Colin is always interested in hearing from potential new PhD students in his areas of research.

http://scholar.google.co.uk/Colin_Green

Qualifications

  • BA (Hons) Economics
  • MSc Health Economics
  • PhD Health Economics

Research

Research interests

Research is being undertaken across a wide range of projects / areas, as listed below, mostly funded by NIHR or other public sector/charitable sources:

I am always interested in hearing from those interested in starting a PhD (intersted in supervision) in research areas of interest.

Research projects

 CURRENT/RECENT

  • Childhood Obesity (Consequences & Causes)
  • Health outcomes (QALYS) for Multiple Sclerosis
  • Health state valuation (patient versus public values; labelling)
  • Modelling disease progression / CEA in Alzheimer's disease and dementia
  • Cost effectiveness of smoking cessation interventions (NIHR funded RCT and CEA)
  • Cardiac rehabilitation NIHR Programme Grant (NIHR): Rehabilitation Enablement in Chronic Heart Failure (REACH HF)
  • Cost effectiveness of healthly lifestyle intervention in the elderly (NIHR funded RCT and CEA; REACT Project)
  • HeLP Trial - obesity prevention in children, NIHR funded trial and economic evaluation (£1.35m).
  • Cost effectiveness of interventions to support people with MS (NHR funded pilot research; BRiMS)

PREVIOUS (selected)

  • ESTEEM Trial - The effectiveness and cost-effectiveness of telephone triage of patients requesting same day consultations in general practice: a cluster randomised controlled trial comparing nurse-led and GP-led management systems. Funded by NIHR Clinical Trials, circa. £2.2 million. [Collaboration with Primary Care Research Group, and others]
  • Clinical trial methods [including economic evaluation/modelling] in neurodegenerative diseases. NIHR Programme Grant for Applied Health Research, funding circa. £2million. This project includes a strong component of methodological research on modelling methods for cost-effectiveness analyses of treatments for Alzheimer's disease and Parkinson's disease. [Collaboration with PCMD Clinical Neurology Research Group, and others]
  • CADET Trial - Multicentre Randomised Controlled Trial of Collaborative Care for Depression. Funded by MRC, circa. £1.7million. [Collaboration with Psychology Dept, Mood Disorders Group, University of Exeter]
  • QALYS and Multiple Sclerosis: Developing a preference-based measure of health-related quality-of-life for MS. Funded by the UK Multiple Sclerosis Society.
  • BacPac Trial - Integrating Behavioural Activation and Physical Activity promotion (BAcPAc): A pilot randomised controlled trial with depressed patients - a collaboration with Psychology and Sports Science.
  • CHUMS - What outcomes of NHS care should be measured for children with neurodisability?
  • EARS - An exploratory trial to evaluate the effects of a physical activity intervention as a smoking cessation induction and cessation aid among the 'hard to reach'. Funded by NIHR HTA Programme, circa. £435,000. [Collaboration with School of Sports & Health Sciences, University of Exeter, and others]
  • CUPID Trial (Multiple Sclerosis) - Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID). Funded by MRC circa. £2million. [Collaboration with PCMD Clinical Neurology Research Group, and others]
  • South West Impact of Multiple Sclerosis (SWIMS) Project - a longitudinal study of MS from the patient perspective. Funded by the MS Society (and others). [Collaboration with PCMD Clinical Neurology Research Group, and others]
  • 'Waste the Waist' - Pilot study for a randomised controlled trial of a primary care based intervention to support lifestyle change for people with high cardiovascular risk. Funded by NIHR Research for Patient Benefit Programme. [Collaboration with Primary Care Research Group, and others]
  • Multi-centre RCT of group-based cognitive behavioural therapy for people with multiple sclerosis. Funded by the Multiple Sclerosis Society, circa. £265,000. [Collaboration with University of Bournemouth, and others]

 

Key publications | Publications by category | Publications by year

Key publications


Gustavsson A, Green C, Jones RW, Förstl H, Simsek D, de Reydet de Vulpillieres F, Luthman S, Adlard N, Bhattacharyya S, Wimo A, et al (2017). Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease. Alzheimers Dement, 13(3), 312-321. Abstract.  Author URL.
Green C, Zhang S (2016). Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model. Alzheimers Dement, 12(7), 776-785. Abstract.  Author URL.  Full text.
Goodwin E, Green C, Spencer A (2015). Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis. Value Health, 18(8), 1025-1036. Abstract.  Author URL.  Full text.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, et al (2015). The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Health Technol Assess, 19(12), vii-187. Abstract.  Author URL.  Full text.
Green C, Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, Cape J, Pilling S, Araya R, et al (2014). Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET). PLoS One, 9(8). Abstract.  Author URL.  Full text.
Campbell JL, Fletcher E, Britten N, Green C, Holt TA, Lattimer V, Richards DA, Richards SH, Salisbury C, Calitri R, et al (2014). Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis. Lancet, 384(9957), 1859-1868. Full text.

Publications by category


Journal articles

Green C, Goodwin E, Hawton A (In Press). ‘Naming and Framing’: the impact of labelling on health state values for multiple sclerosis. Medical Decision Making Full text.
Gustavsson A, Green C, Jones RW, Förstl H, Simsek D, de Reydet de Vulpillieres F, Luthman S, Adlard N, Bhattacharyya S, Wimo A, et al (2017). Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease. Alzheimers Dement, 13(3), 312-321. Abstract.  Author URL.
Goodwin E, Green C (2016). A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health. Appl Health Econ Health Policy, 14(2), 161-183. Abstract.  Author URL.  Full text.
Thompson TP, Greaves CJ, Ayres R, Aveyard P, Warren FC, Byng R, Taylor RS, Campbell JL, Ussher M, Green C, et al (2016). An Exploratory Analysis of the Smoking and Physical Activity Outcomes from a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups. Nicotine Tob Res, 18(3), 289-297. Abstract.  Author URL.  Full text.
Richards DA, Bower P, Chew-Graham C, Gask L, Lovell K, Cape J, Pilling S, Araya R, Kessler D, Barkham M, et al (2016). Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technol Assess, 20(14), 1-192. Abstract.  Author URL.
Creanor S, Lloyd J, Hillsdon M, Dean S, Green C, Taylor RS, Ryan E, Wyatt K, HeLP Trial Management Group (2016). Detailed statistical analysis plan for a cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children. Trials, 17(1). Abstract.  Author URL.  Full text.
Hawton A, Green C (2016). Health Utilities for Multiple Sclerosis. Value in Health, 19(4), 460-468. Full text.
Hawton AJ, Green C (2016). Multiple sclerosis: relapses, resource use, and costs. Eur J Health Econ, 17(7), 875-884. Abstract.  Author URL.  Full text.
Green C, Zhang S (2016). Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model. Alzheimers Dement, 12(7), 776-785. Abstract.  Author URL.  Full text.
Eyre V, Lang CC, Smith K, Jolly K, Davis R, Hayward C, Wingham J, Abraham C, Green C, Warren FC, et al (2016). Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial. BMJ Open, 6(10). Abstract.  Author URL.  Full text.
Freeman JA, Hendrie W, Creanor S, Jarrett L, Barton A, Green C, Marsden J, Rogers E, Zajicek J (2016). Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. BMC Neurol, 16 Abstract.  Author URL.  Full text.
Holt T, Fletcher E, Warren F, Richards S, Calitri R, Green C (2016). Telephone triage systems in UK general practice: analysis of consultation duration during the index day in a pragmatic randomised controlled trial. Br J Gen Pract Full text.
Goodwin E, Green C (2015). A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure. Value Health, 18(8), 1016-1024. Abstract.  Author URL.  Full text.
Janssens A, Thompson-Coon J, Rogers M, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C (2015). A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive Characteristics. Value in Health Full text.
Janssens A, Rogers M, Thompson Coon J, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C (2015). A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II: Evaluation of Psychometric Performance of English-Language Versions in a General Population. Value in Health, 18(2), 334-345. Full text.
Taylor RS, Hayward C, Eyre V, Austin J, Davies R, Doherty P, Jolly K, Wingham J, Van Lingen R, Abraham C, et al (2015). Clinical effectiveness and cost-effectiveness of the Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) facilitated self-care rehabilitation intervention in heart failure patients and caregivers: rationale and protocol for a multicentre randomised controlled trial. BMJ Open, 5(12). Abstract.  Author URL.  Full text.
Pentecost C, Farrand P, Greaves CJ, Taylor RS, Warren FC, Hillsdon M, Green C, Welsman JR, Rayson K, Evans PH, et al (2015). Combining behavioural activation with physical activity promotion for adults with depression: findings of a parallel-group pilot randomised controlled trial (BAcPAc). Trials, 16(367), 1-15. Abstract.  Full text.
Goodwin E, Green C, Spencer A (2015). Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis. Value Health, 18(8), 1025-1036. Abstract.  Author URL.  Full text.
Murdoch J, Varley A, Fletcher E, Britten N, Price L, Calitri R, Green C, Lattimer V, Richards SH, Richards DA, et al (2015). Implementing telephone triage in general practice: a process evaluation of a cluster randomised controlled trial. BMC Fam Pract, 16 Abstract.  Author URL.  Full text.
Morris C, Janssens A, Shilling V, Allard A, Fellowes A, Tomlinson R, Williams J, Thompson Coon J, Rogers M, Beresford B, et al (2015). Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures. Health Qual Life Outcomes, 13 Abstract.  Author URL.  Full text.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, et al (2015). The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Health Technol Assess, 19(12), vii-187. Abstract.  Author URL.  Full text.
Campbell JL, Fletcher E, Britten N, Green C, Holt T, Lattimer V, Richards DA, Richards SH, Salisbury C, Taylor RS, et al (2015). The clinical effectiveness and cost-effectiveness of telephone triage for managing same-day consultation requests in general practice: a cluster randomised controlled trial comparing general practitioner-led and nurse-led management systems with usual care (the ESTEEM trial). Health Technol Assess, 19(13), 1-viii. Abstract.  Author URL.  Full text.
Greaves C, Gillison F, Stathi A, Bennett P, Reddy P, Dunbar J, Perry R, Messom D, Chandler R, Francis M, et al (2015). Waste the Waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. International Journal of Behavioral Nutrition and Physical Activity, 12, 1-13. Abstract.  Full text.
Taylor AH, Thompson TP, Greaves CJ, Taylor RS, Green C, Warren FC, Kandiyali R, Aveyard P, Ayres R, Byng R, et al (2014). A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers. Health Technol Assess, 18(4), 1-324. Abstract.  Author URL.  Full text.
Farrand P, Pentecost C, Greaves C, Taylor RS, Warren F, Green C, Hillsdon M, Evans P, Welsman J, Taylor AH, et al (2014). A written self-help intervention for depressed adults comparing behavioural activation combined with physical activity promotion with a self-help intervention based upon behavioural activation alone: study protocol for a parallel group pilot randomised controlled trial (BAcPAc). Trials, 15 Abstract.  Author URL.  Full text.
Green C, Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, Cape J, Pilling S, Araya R, et al (2014). Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET). PLoS One, 9(8). Abstract.  Author URL.  Full text.
Morris C, Janssens A, Allard A, Thompson Coon J, Shilling V, Tomlinson R, Williams J, Fellowes A, Rogers M, Fellowes A, et al (2014). Informing the NHS Outcomes Framework: evaluating meaningful health outcomes for children with neurodisability using multiple methods including systematic review, qualitative research, Delphi survey and consensus meeting. Health Serv Deliv Res, 15(2). Author URL.
Campbell JL, Fletcher E, Britten N, Green C, Holt TA, Lattimer V, Richards DA, Richards SH, Salisbury C, Calitri R, et al (2014). Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis. Lancet, 384(9957), 1859-1868. Full text.
Thomas S, Thomas PW, Kersten P, Jones R, Green C, Nock A, Slingsby V, Smith AD, Baker R, Galvin KT, et al (2013). A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1092-1099. Abstract.  Full text.
Eldabe S, Kern M, Peul W, Green C, Winterfeldt K, Taylor RS (2013). Assessing the effectiveness and cost effectiveness of subcutaneous nerve stimulation in patients with predominant back pain due to failed back surgery syndrome (SubQStim study): study protocol for a multicenter randomized controlled trial. Trials, 14 Abstract.  Author URL.  Full text.
Richards D, Hill J, Gask L, Lovell K, Chew-Graham C, Bower P, Cape J, Pilling S, Araya R, Kessler D, et al (2013). Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ: British Medical Journal, 347 Abstract.  Full text.
Telford C, Green C, Logan S, Langley K, Thapar A, Ford T (2013). Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol, 48(2), 337-344. Abstract.  Author URL.
Walsh N, Cramp F, Palmer S, Pollock J, Hampson L, Gooberman-Hill R, Green C, Jones L, Phillips S, Johnson L, et al (2013). Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocol. Physiotherapy (United Kingdom), 99(4), 352-357. Abstract.
Escudero J, Ifeachor E, Zajicek JP, Green C, Shearer J, Pearson S, Neuroimaging AD (2013). Machine Learning-Based Method for Personalized and Cost-Effective Detection of Alzheimer's Disease. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 60(1), 164-168. Author URL.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2013). Republished research: Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. Br J Sports Med, 47(8). Author URL.
Hawton A, Shearer J, Goodwin E, Green C (2013). Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis. Appl Health Econ Health Policy, 11(4), 331-341. Abstract.  Author URL.
Wyatt KM, Lloyd JJ, Abraham C, Creanor S, Dean S, Densham E, Daurge W, Green C, Hillsdon M, Pearson V, et al (2013). The Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children: study protocol for a randomised controlled trial. Trials, 14 Abstract.  Author URL.  Full text.
Campbell JL, Britten N, Green C, Holt TA, Lattimer V, Richards SH, Richards DA, Salisbury C, Taylor RS, Fletcher E, et al (2013). The effectiveness and cost-effectiveness of telephone triage of patients requesting same day consultations in general practice: study protocol for a cluster randomised controlled trial comparing nurse-led and GP-led management systems (ESTEEM). Trials, 14 Abstract.  Author URL.  Full text.
Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VMY, Baumgart M, Banerjee S, Beck C, Blennow K, et al (2012). Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit. Alzheimer's and Dementia, 8(5), 445-452. Abstract.
Walsh N, Cramp F, Palmer S, Pollock J, Hampson L, Gooberman-Hill R, Green C, Jones L, Phillips S, Johnson L, et al (2012). Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocol. Physiotherapy (United Kingdom)
Shearer J, Green C, Ritchie CW, Zajicek JP (2012). Health state values for use in the economic evaluation of treatments for Alzheimer's disease. Drugs Aging, 29(1), 31-43. Abstract.  Author URL.
Green C, Auguste P, Lloyd JJ, Wyatt K (2012). Modelling future outcomes to estimate the cost effectiveness of interventions related to child and adolescent overweight and obesity. The Lancet
Anokye NK, Trueman P, Green C, Pavey TG, Taylor RS (2012). Physical activity and health related quality of life. BMC Public Health, 12(1). Abstract.  Full text.
Shearer J, Green C, Counsell CE, Zajicek JP (2012). The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. J Neurol, 259(3), 462-468. Abstract.  Author URL.
Hawton A, Green C, Telford CJ, Wright DE, Zajicek JP (2012). The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Mult Scler, 18(6), 853-861. Abstract.  Author URL.  Full text.
Hawton A, Green C, Telford C, Zajicek J, Wright D (2012). Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health, 15(8), 1084-1091. Abstract.  Author URL.
Dickens AP, Richards SH, Hawton A, Taylor RS, Greaves CJ, Green C, Edwards R, Campbell JL (2011). An evaluation of the effectiveness of a community mentoring service for socially isolated older people: a controlled trial. BMC Public Health, 11 Abstract.  Author URL.  Full text.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2011). Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: Systematic review and meta-analysis. BMJ (Online), 343(7831). Abstract.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2011). Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ, 343 Abstract.  Author URL.  Full text.
Green C, Shearer J, Ritchie CW, Zajicek JP (2011). Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression. Value Health, 14(5), 621-630. Abstract.  Author URL.
Pavey TG, Anokye N, Taylor AH, Trueman P, Moxham T, Fox KR, Hillsdon M, Green C, Campbell JL, Foster C, et al (2011). The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess, 15(44), i-254. Abstract.  Author URL.  Full text.
Anokye NK, Trueman P, Green C, Pavey TG, Hillsdon M, Taylor RS (2011). The cost-effectiveness of exercise referral schemes. BMC Public Health, 11 Abstract.  Author URL.  Full text.
Hawton A, Green C, Dickens AP, Richards SH, Taylor RS, Edwards R, Greaves CJ, Campbell JL (2011). The impact of social isolation on the health status and health-related quality of life of older people. Qual Life Res, 20(1), 57-67. Abstract.  Author URL.
Shearer J, Green C, Counsell CE, Zajicek JP (2011). The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal. Appl Health Econ Health Policy, 9(4), 243-258. Abstract.  Author URL.
Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, Stein K (2010). Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess, 14(2), 1-iv. Abstract.  Author URL.  Full text.
Dalal H, Austin J, Davis R, Jolly K, Green C, Lewin B, Taylor R, Thompson D, Williams R, Wingham J, et al (2010). Congestive heart failure. Don't forget rehabilitation. BMJ, 341 Author URL.
Green C (2010). Considering the value associated with innovation in health technology appraisal decisions (deliberations): a NICE thing to do?. Appl Health Econ Health Policy, 8(1), 1-5. Author URL.
Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T, Stein K (2010). Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health, 13(1), 55-60. Abstract.  Author URL.
Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T, Stein K (2010). Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health, 13(1), 61-68. Abstract.  Author URL.
Thomas PW, Thomas S, Kersten P, Jones R, Nock A, Slingsby V, Green C, Baker R, Galvin K, Hillier C, et al (2010). Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis. BMC Neurology, 10 Abstract.  Full text.
Raftery J, Hanney S, Green C, Buxton M (2009). Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach. Int J Technol Assess Health Care, 25(1), 1-5. Abstract.  Author URL.
Green C, Bryant J, Takeda A, Cooper K, Clegg A, Smith A, Stephens M (2009). Bortezomib for the treatment of multiple myeloma patients. Health Technol Assess, 13 Suppl 1, 29-33. Abstract.  Author URL.  Full text.
Richards DA, Hughes-Morley A, Hayes RA, Araya R, Barkham M, Bland JM, Bower P, Cape J, Chew-Graham CA, Gask L, et al (2009). Collaborative Depression Trial (CADET): multi-centre randomised controlled trial of collaborative care for depression--study protocol. BMC Health Serv Res, 9 Abstract.  Author URL.  Full text.
Green C, Gerard K (2009). Exploring the social value of health-care interventions: a stated preference discrete choice experiment. Health Econ, 18(8), 951-976. Abstract.  Author URL.
Green C (2009). Investigating public preferences on 'severity of health' as a relevant condition for setting healthcare priorities. Soc Sci Med, 68(12), 2247-2255. Abstract.  Author URL.
Thompson Coon JS, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, Stein K (2009). Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer, 101(2), 238-243. Abstract.  Author URL.  Full text.
Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectivemess of different inhaled corticosteroids and their usage with long-acting Beta-agonists for the treatment of chronic asthma in adults and children agerd 12 years and over. Health Technology Assessment, 12(9). Full text.
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess, 12(20), 1-iv. Abstract.  Author URL.  Full text.
Hanney S, Buxton M, Green C, Coulson D, Raftery J (2007). An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess, 11(53), iii-180. Abstract.  Author URL.  Full text.
Green C, Main C, Shepherd J, Anderson A (2007). Inhaled corticosteroids and long-acting beta2-agonists for the treatment of chronic asthma in children under the age of 12 years: Systematic review and economic analysis. Health Technology Assessment
Green C (2007). Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. Pharmacoeconomics, 25(9), 735-750. Abstract.  Author URL.
Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS (2007). The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess, 11(21), iii-93. Abstract.  Author URL.  Full text.
Kirby J, Green C, Loveman E, Clegg A, Picot J, Takeda A, Payne E (2006). A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease. Drugs Aging, 23(3), 227-240. Abstract.  Author URL.
Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C (2006). A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry, 21(1), 17-28. Abstract.  Author URL.
Green C, Dinnes J, Takeda AL, Cuthbertson BH (2006). Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Int J Technol Assess Health Care, 22(1), 90-100. Abstract.  Author URL.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2006). Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease - the authors' reply. PHARMACOECONOMICS, 24(6), 625-626. Author URL.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2006). The authors' reply [2]. PharmacoEconomics, 24(6), 625-626.
Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, Cave C, Payne E, Cuthbertson BH (2005). Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. Health Technol Assess, 9(11), 1-iv. Abstract.  Author URL.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2005). Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease. Pharmacoeconomics, 23(12), 1271-1282. Abstract.  Author URL.
Green C, Colquitt JL, Kirby J, Davidson P (2005). Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol, 152(1), 130-141. Abstract.  Author URL.
Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N (2004). Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess, 8(43), iii-171. Abstract.  Author URL.
Green C, Colquitt JL, Kirby J, Davidson P, Payne E (2004). Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess, 8(47), iii-120. Abstract.  Author URL.
Brazier J, Green C, McCabe C, Stevens K (2003). A review of VAS in economic evaluation. Journal of Pharmacoeconomics and Outcomes Research, 3(3), 293-302.
Green C, Kiebert G, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN (2003). Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Qual Life Res, 12(5), 565-574. Abstract.  Author URL.
Grieve R, Hutton J, Green C (2003). Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular field. Health Policy, 64(3), 311-324. Abstract.  Author URL.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 7(22), iii, 1-190.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 7(22). Abstract.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health Technol Assess, 7(22), iii-190. Abstract.  Author URL.
Brazier J, Green C, McCabe C, Stevens K (2003). Use of visual analog scales in economic evaluation. Expert Review of Pharmacoeconomics and Outcomes Research, 3(3), 293-302. Abstract.
Brazier JE, Green C, Kanis JA, Committee of Scientific Advisors International Osteoporosis Foundation (2002). A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int, 13(10), 768-776. Abstract.  Author URL.
Field D, Draper ES, Gompels MJ, Green C (2001). Measuring later health status of high risk infants: randomised comparison of two simple methods of data collection. BMJ, 323(7324), 1276-1280.
Green C (2001). On the societal value of health care: what do we know about the person trade-off technique?. Health Econ, 10(3), 233-243. Abstract.  Author URL.
Kiebert GM, Green C, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN (2001). Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci, 191(1-2), 87-93. Abstract.  Author URL.
Green C, Brazier J, Deverill M (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151-165. Abstract.  Author URL.
Brazier J, Deverill M, Green C (1999). A review of the use of health status measures in economic evaluation. J Health Serv Res Policy, 4(3), 174-184. Abstract.  Author URL.
Dixon S, Green C (1999). Measuring outcomes in economic evaluations. This economics note is misleading. BMJ, 319(7211). Author URL.
Green C, Akehurst R (1998). New therapeutic products and difficult decisions. The case of recombinant factor VIII in the management of haemophilia A. J Public Health Med, 20(2), 137-138. Abstract.  Author URL.
Deverill M, Brazier J, Green C, Booth A (1998). The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art. Pharmacoeconomics, 13(4), 411-420. Abstract.  Author URL.
Dolan P, Green C (1998). Using the PTO method to examine differences between individual and social values. Health Economics, 7(4), 307-312.

Chapters

Green C (2006). Pharmacoeconomic Studies in Alzheimer's Disease. In Ritchie CW, Ames DJ, Masters CL, Cummings J (Eds.) Treatment Strategies in Alzheimer's Disease and other Dementias, Oxford: Clinical Publishing.
Deverill M, Brazier JE, Green C (2001). The use of health status measures in economic evaluation. In Stevens A, Abrams K, Brazier J (Eds.) The Advanced Handbook of Methods in Evidence Based Healthcare, London: SAGE.
Brazier J, Green C (1997). Economic evaluation in brief. In  (Ed) The Royal London Trauma Hospital: Trauma Care, London:.

Conferences

Bottomley C, Padania S, Lloyd A, Gary B, Green C, Adlard N (2016). UK PATIENT PREFERENCE FOR CHARACTERISTICS OF DMTS IN MS.  Author URL.
Hawton A, Green C (2014). Generic preference-based measures for use with people with multiple sclerosis: are they appropriate?.  Author URL.
Goodwin E, Green C (2014). Improving the measurement of QALYs in multiple sclerosis: Estimating a preference-based index for use in deriving quality-adjusted life-years (QALYs) for multiple sclerosis.  Author URL.
Green C, Zhang S (2014). MODELING DISEASE PROGRESSION IN ALZHEIMER'S DEMENTIA TO INFORM HTA (CEA).  Author URL.
Green C, Shearer J, Zajicek J (2013). COSTS ASSOCIATED WITH THE IMPACT OF PROGRESSIVE MULTIPLE SCLEROSIS: INSIGHTS FROM a THREE YEAR CLINICAL TRIAL (THE CUPID TRIAL).  Author URL.
Green C, Shearer J, Zajicek J (2013). Costs associated with the impact of progressive multiple sclerosis: insights from a three year clinical trial (the CUPID trial).  Author URL.
Green C, Hawton A, Zajicek J (2013). HEALTH STATE (QALY) VALUES FOR MULTIPLE SCLEROSIS: a REPORT USING DATA FROM THE UNITED KINGDOM SOUTH WEST IMPACT OF MULTIPLE SCLEROSIS (SWIMS) STUDY.  Author URL.
Green C, Hawton A, Zajicek J (2013). Health state (QALY) values for multiple sclerosis: a report using data from the UK South West Impact of Multiple Sclerosis (SWIMS) Study.  Author URL.
Hawton AJ, Green C, Zajicek J, Wright D (2013). Health state (QALY) values for multiple sclerosis: Improving the quality of information used in cost-effectiveness analyses of treatments for MS.  Author URL.
Goodwin E, Green C (2013). Improving the measurement of QALYs in multiple sclerosis: Developing a patient-reported health descriptive system for use in deriving quality-adjusted life-years (QALYs) for multiple sclerosis.  Author URL.
Green C, Goodwin E (2013). Improving the measurement of quality of life adjusted years (QALYs) in multiple sclerosis: developing a patient-reported health descriptive system for use in deriving values fo multiple sclerosis-specific QALYs.  Author URL.
Akehurst R, Anderson P, Brazier J, Brennan A, Briggs A, Buxton M, Cairns J, Calvert N, Claxton K, Dixon S, et al (2000). Decision analytic modelling in the economic evaluation of health technologies - a consensus statement.  Author URL.

Publications by year


In Press

Green C, Goodwin E, Hawton A (In Press). ‘Naming and Framing’: the impact of labelling on health state values for multiple sclerosis. Medical Decision Making Full text.

2017

Gustavsson A, Green C, Jones RW, Förstl H, Simsek D, de Reydet de Vulpillieres F, Luthman S, Adlard N, Bhattacharyya S, Wimo A, et al (2017). Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease. Alzheimers Dement, 13(3), 312-321. Abstract.  Author URL.

2016

Goodwin E, Green C (2016). A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health. Appl Health Econ Health Policy, 14(2), 161-183. Abstract.  Author URL.  Full text.
Thompson TP, Greaves CJ, Ayres R, Aveyard P, Warren FC, Byng R, Taylor RS, Campbell JL, Ussher M, Green C, et al (2016). An Exploratory Analysis of the Smoking and Physical Activity Outcomes from a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups. Nicotine Tob Res, 18(3), 289-297. Abstract.  Author URL.  Full text.
Richards DA, Bower P, Chew-Graham C, Gask L, Lovell K, Cape J, Pilling S, Araya R, Kessler D, Barkham M, et al (2016). Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial. Health Technol Assess, 20(14), 1-192. Abstract.  Author URL.
Creanor S, Lloyd J, Hillsdon M, Dean S, Green C, Taylor RS, Ryan E, Wyatt K, HeLP Trial Management Group (2016). Detailed statistical analysis plan for a cluster randomised controlled trial of the Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children. Trials, 17(1). Abstract.  Author URL.  Full text.
Hawton A, Green C (2016). Health Utilities for Multiple Sclerosis. Value in Health, 19(4), 460-468. Full text.
Hawton AJ, Green C (2016). Multiple sclerosis: relapses, resource use, and costs. Eur J Health Econ, 17(7), 875-884. Abstract.  Author URL.  Full text.
Green C, Zhang S (2016). Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model. Alzheimers Dement, 12(7), 776-785. Abstract.  Author URL.  Full text.
Eyre V, Lang CC, Smith K, Jolly K, Davis R, Hayward C, Wingham J, Abraham C, Green C, Warren FC, et al (2016). Rehabilitation Enablement in Chronic Heart Failure-a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial. BMJ Open, 6(10). Abstract.  Author URL.  Full text.
Freeman JA, Hendrie W, Creanor S, Jarrett L, Barton A, Green C, Marsden J, Rogers E, Zajicek J (2016). Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis. BMC Neurol, 16 Abstract.  Author URL.  Full text.
Holt T, Fletcher E, Warren F, Richards S, Calitri R, Green C (2016). Telephone triage systems in UK general practice: analysis of consultation duration during the index day in a pragmatic randomised controlled trial. Br J Gen Pract Full text.
Bottomley C, Padania S, Lloyd A, Gary B, Green C, Adlard N (2016). UK PATIENT PREFERENCE FOR CHARACTERISTICS OF DMTS IN MS.  Author URL.

2015

Goodwin E, Green C (2015). A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure. Value Health, 18(8), 1016-1024. Abstract.  Author URL.  Full text.
Janssens A, Thompson-Coon J, Rogers M, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C (2015). A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I: Descriptive Characteristics. Value in Health Full text.
Janssens A, Rogers M, Thompson Coon J, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C (2015). A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II: Evaluation of Psychometric Performance of English-Language Versions in a General Population. Value in Health, 18(2), 334-345. Full text.
Taylor RS, Hayward C, Eyre V, Austin J, Davies R, Doherty P, Jolly K, Wingham J, Van Lingen R, Abraham C, et al (2015). Clinical effectiveness and cost-effectiveness of the Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) facilitated self-care rehabilitation intervention in heart failure patients and caregivers: rationale and protocol for a multicentre randomised controlled trial. BMJ Open, 5(12). Abstract.  Author URL.  Full text.
Pentecost C, Farrand P, Greaves CJ, Taylor RS, Warren FC, Hillsdon M, Green C, Welsman JR, Rayson K, Evans PH, et al (2015). Combining behavioural activation with physical activity promotion for adults with depression: findings of a parallel-group pilot randomised controlled trial (BAcPAc). Trials, 16(367), 1-15. Abstract.  Full text.
Goodwin E, Green C, Spencer A (2015). Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis. Value Health, 18(8), 1025-1036. Abstract.  Author URL.  Full text.
Murdoch J, Varley A, Fletcher E, Britten N, Price L, Calitri R, Green C, Lattimer V, Richards SH, Richards DA, et al (2015). Implementing telephone triage in general practice: a process evaluation of a cluster randomised controlled trial. BMC Fam Pract, 16 Abstract.  Author URL.  Full text.
Morris C, Janssens A, Shilling V, Allard A, Fellowes A, Tomlinson R, Williams J, Thompson Coon J, Rogers M, Beresford B, et al (2015). Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures. Health Qual Life Outcomes, 13 Abstract.  Author URL.  Full text.
Campbell J, Warren F, Taylor R, Green C, Salisbury C (2015). Patient perspectives on telephone triage in general practice - authors' reply. Lancet, 385(9969). Author URL.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano MG, MacManus D, Miller D, et al (2015). The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Health Technol Assess, 19(12), vii-187. Abstract.  Author URL.  Full text.
Campbell JL, Fletcher E, Britten N, Green C, Holt T, Lattimer V, Richards DA, Richards SH, Salisbury C, Taylor RS, et al (2015). The clinical effectiveness and cost-effectiveness of telephone triage for managing same-day consultation requests in general practice: a cluster randomised controlled trial comparing general practitioner-led and nurse-led management systems with usual care (the ESTEEM trial). Health Technol Assess, 19(13), 1-viii. Abstract.  Author URL.  Full text.
Greaves C, Gillison F, Stathi A, Bennett P, Reddy P, Dunbar J, Perry R, Messom D, Chandler R, Francis M, et al (2015). Waste the Waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. International Journal of Behavioral Nutrition and Physical Activity, 12, 1-13. Abstract.  Full text.

2014

Taylor AH, Thompson TP, Greaves CJ, Taylor RS, Green C, Warren FC, Kandiyali R, Aveyard P, Ayres R, Byng R, et al (2014). A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers. Health Technol Assess, 18(4), 1-324. Abstract.  Author URL.  Full text.
Farrand P, Pentecost C, Greaves C, Taylor RS, Warren F, Green C, Hillsdon M, Evans P, Welsman J, Taylor AH, et al (2014). A written self-help intervention for depressed adults comparing behavioural activation combined with physical activity promotion with a self-help intervention based upon behavioural activation alone: study protocol for a parallel group pilot randomised controlled trial (BAcPAc). Trials, 15 Abstract.  Author URL.  Full text.
Green C, Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, Cape J, Pilling S, Araya R, et al (2014). Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET). PLoS One, 9(8). Abstract.  Author URL.  Full text.
Hawton A, Green C (2014). Generic preference-based measures for use with people with multiple sclerosis: are they appropriate?.  Author URL.
Goodwin E, Green C (2014). Improving the measurement of QALYs in multiple sclerosis: Estimating a preference-based index for use in deriving quality-adjusted life-years (QALYs) for multiple sclerosis.  Author URL.
Morris C, Janssens A, Allard A, Thompson Coon J, Shilling V, Tomlinson R, Williams J, Fellowes A, Rogers M, Fellowes A, et al (2014). Informing the NHS Outcomes Framework: evaluating meaningful health outcomes for children with neurodisability using multiple methods including systematic review, qualitative research, Delphi survey and consensus meeting. Health Serv Deliv Res, 15(2). Author URL.
Green C, Zhang S (2014). MODELING DISEASE PROGRESSION IN ALZHEIMER'S DEMENTIA TO INFORM HTA (CEA).  Author URL.
Campbell JL, Fletcher E, Britten N, Green C, Holt TA, Lattimer V, Richards DA, Richards SH, Salisbury C, Calitri R, et al (2014). Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis. Lancet, 384(9957), 1859-1868. Full text.

2013

Thomas S, Thomas PW, Kersten P, Jones R, Green C, Nock A, Slingsby V, Smith AD, Baker R, Galvin KT, et al (2013). A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 84(10), 1092-1099. Abstract.  Full text.
Eldabe S, Kern M, Peul W, Green C, Winterfeldt K, Taylor RS (2013). Assessing the effectiveness and cost effectiveness of subcutaneous nerve stimulation in patients with predominant back pain due to failed back surgery syndrome (SubQStim study): study protocol for a multicenter randomized controlled trial. Trials, 14 Abstract.  Author URL.  Full text.
Green C, Shearer J, Zajicek J (2013). COSTS ASSOCIATED WITH THE IMPACT OF PROGRESSIVE MULTIPLE SCLEROSIS: INSIGHTS FROM a THREE YEAR CLINICAL TRIAL (THE CUPID TRIAL).  Author URL.
Richards D, Hill J, Gask L, Lovell K, Chew-Graham C, Bower P, Cape J, Pilling S, Araya R, Kessler D, et al (2013). Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ: British Medical Journal, 347 Abstract.  Full text.
Green C, Shearer J, Zajicek J (2013). Costs associated with the impact of progressive multiple sclerosis: insights from a three year clinical trial (the CUPID trial).  Author URL.
Telford C, Green C, Logan S, Langley K, Thapar A, Ford T (2013). Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder. Soc Psychiatry Psychiatr Epidemiol, 48(2), 337-344. Abstract.  Author URL.
Walsh N, Cramp F, Palmer S, Pollock J, Hampson L, Gooberman-Hill R, Green C, Jones L, Phillips S, Johnson L, et al (2013). Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocol. Physiotherapy (United Kingdom), 99(4), 352-357. Abstract.
Green C, Hawton A, Zajicek J (2013). HEALTH STATE (QALY) VALUES FOR MULTIPLE SCLEROSIS: a REPORT USING DATA FROM THE UNITED KINGDOM SOUTH WEST IMPACT OF MULTIPLE SCLEROSIS (SWIMS) STUDY.  Author URL.
Green C, Hawton A, Zajicek J (2013). Health state (QALY) values for multiple sclerosis: a report using data from the UK South West Impact of Multiple Sclerosis (SWIMS) Study.  Author URL.
Hawton AJ, Green C, Zajicek J, Wright D (2013). Health state (QALY) values for multiple sclerosis: Improving the quality of information used in cost-effectiveness analyses of treatments for MS.  Author URL.
Goodwin E, Green C (2013). Improving the measurement of QALYs in multiple sclerosis: Developing a patient-reported health descriptive system for use in deriving quality-adjusted life-years (QALYs) for multiple sclerosis.  Author URL.
Green C, Goodwin E (2013). Improving the measurement of quality of life adjusted years (QALYs) in multiple sclerosis: developing a patient-reported health descriptive system for use in deriving values fo multiple sclerosis-specific QALYs.  Author URL.
Escudero J, Ifeachor E, Zajicek JP, Green C, Shearer J, Pearson S, Neuroimaging AD (2013). Machine Learning-Based Method for Personalized and Cost-Effective Detection of Alzheimer's Disease. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 60(1), 164-168. Author URL.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2013). Republished research: Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. Br J Sports Med, 47(8). Author URL.
Hawton A, Shearer J, Goodwin E, Green C (2013). Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis. Appl Health Econ Health Policy, 11(4), 331-341. Abstract.  Author URL.
Wyatt KM, Lloyd JJ, Abraham C, Creanor S, Dean S, Densham E, Daurge W, Green C, Hillsdon M, Pearson V, et al (2013). The Healthy Lifestyles Programme (HeLP), a novel school-based intervention to prevent obesity in school children: study protocol for a randomised controlled trial. Trials, 14 Abstract.  Author URL.  Full text.
Campbell JL, Britten N, Green C, Holt TA, Lattimer V, Richards SH, Richards DA, Salisbury C, Taylor RS, Fletcher E, et al (2013). The effectiveness and cost-effectiveness of telephone triage of patients requesting same day consultations in general practice: study protocol for a cluster randomised controlled trial comparing nurse-led and GP-led management systems (ESTEEM). Trials, 14 Abstract.  Author URL.  Full text.

2012

Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VMY, Baumgart M, Banerjee S, Beck C, Blennow K, et al (2012). Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit. Alzheimer's and Dementia, 8(5), 445-452. Abstract.
Green C (2012). Applied Methods of Cost-Benefit Analysis in Health Care. JOURNAL OF PUBLIC HEALTH, 34(2), 317-317. Author URL.
Walsh N, Cramp F, Palmer S, Pollock J, Hampson L, Gooberman-Hill R, Green C, Jones L, Phillips S, Johnson L, et al (2012). Exercise and self-management for people with chronic knee, hip or lower back pain: a cluster randomised controlled trial of clinical and cost-effectiveness. Study protocol. Physiotherapy (United Kingdom)
Shearer J, Green C, Ritchie CW, Zajicek JP (2012). Health state values for use in the economic evaluation of treatments for Alzheimer's disease. Drugs Aging, 29(1), 31-43. Abstract.  Author URL.
Green C, Auguste P, Lloyd JJ, Wyatt K (2012). Modelling future outcomes to estimate the cost effectiveness of interventions related to child and adolescent overweight and obesity. The Lancet
Anokye NK, Trueman P, Green C, Pavey TG, Taylor RS (2012). Physical activity and health related quality of life. BMC Public Health, 12(1). Abstract.  Full text.
Shearer J, Green C, Counsell CE, Zajicek JP (2012). The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease. J Neurol, 259(3), 462-468. Abstract.  Author URL.
Hawton A, Green C, Telford CJ, Wright DE, Zajicek JP (2012). The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Mult Scler, 18(6), 853-861. Abstract.  Author URL.  Full text.
Hawton A, Green C, Telford C, Zajicek J, Wright D (2012). Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health, 15(8), 1084-1091. Abstract.  Author URL.

2011

Dickens AP, Richards SH, Hawton A, Taylor RS, Greaves CJ, Green C, Edwards R, Campbell JL (2011). An evaluation of the effectiveness of a community mentoring service for socially isolated older people: a controlled trial. BMC Public Health, 11 Abstract.  Author URL.  Full text.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2011). Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: Systematic review and meta-analysis. BMJ (Online), 343(7831). Abstract.
Pavey TG, Taylor AH, Fox KR, Hillsdon M, Anokye N, Campbell JL, Foster C, Green C, Moxham T, Mutrie N, et al (2011). Effect of exercise referral schemes in primary care on physical activity and improving health outcomes: systematic review and meta-analysis. BMJ, 343 Abstract.  Author URL.  Full text.
Green C, Shearer J, Ritchie CW, Zajicek JP (2011). Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression. Value Health, 14(5), 621-630. Abstract.  Author URL.
Pavey TG, Anokye N, Taylor AH, Trueman P, Moxham T, Fox KR, Hillsdon M, Green C, Campbell JL, Foster C, et al (2011). The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation. Health Technol Assess, 15(44), i-254. Abstract.  Author URL.  Full text.
Anokye NK, Trueman P, Green C, Pavey TG, Hillsdon M, Taylor RS (2011). The cost-effectiveness of exercise referral schemes. BMC Public Health, 11 Abstract.  Author URL.  Full text.
Hawton A, Green C, Dickens AP, Richards SH, Taylor RS, Edwards R, Greaves CJ, Campbell JL (2011). The impact of social isolation on the health status and health-related quality of life of older people. Qual Life Res, 20(1), 57-67. Abstract.  Author URL.
Shearer J, Green C, Counsell CE, Zajicek JP (2011). The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal. Appl Health Econ Health Policy, 9(4), 243-258. Abstract.  Author URL.

2010

Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, Stein K (2010). Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess, 14(2), 1-iv. Abstract.  Author URL.  Full text.
Dalal H, Austin J, Davis R, Jolly K, Green C, Lewin B, Taylor R, Thompson D, Williams R, Wingham J, et al (2010). Congestive heart failure. Don't forget rehabilitation. BMJ, 341 Author URL.
Green C (2010). Considering the value associated with innovation in health technology appraisal decisions (deliberations): a NICE thing to do?. Appl Health Econ Health Policy, 8(1), 1-5. Author URL.
Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T, Stein K (2010). Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health, 13(1), 55-60. Abstract.  Author URL.
Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T, Stein K (2010). Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health, 13(1), 61-68. Abstract.  Author URL.
Thomas PW, Thomas S, Kersten P, Jones R, Nock A, Slingsby V, Green C, Baker R, Galvin K, Hillier C, et al (2010). Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis. BMC Neurology, 10 Abstract.  Full text.
Coon JST, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, Stein K (2010). Reply: SUN vs BEV\+IFN in first-line mRCC therapy: No evidence for a statistically significant difference in progression-free survival. British Journal of Cancer, 102(1), 234-235. Full text.

2009

Raftery J, Hanney S, Green C, Buxton M (2009). Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach. Int J Technol Assess Health Care, 25(1), 1-5. Abstract.  Author URL.
Green C, Bryant J, Takeda A, Cooper K, Clegg A, Smith A, Stephens M (2009). Bortezomib for the treatment of multiple myeloma patients. Health Technol Assess, 13 Suppl 1, 29-33. Abstract.  Author URL.  Full text.
Richards DA, Hughes-Morley A, Hayes RA, Araya R, Barkham M, Bland JM, Bower P, Cape J, Chew-Graham CA, Gask L, et al (2009). Collaborative Depression Trial (CADET): multi-centre randomised controlled trial of collaborative care for depression--study protocol. BMC Health Serv Res, 9 Abstract.  Author URL.  Full text.
Green C, Gerard K (2009). Exploring the social value of health-care interventions: a stated preference discrete choice experiment. Health Econ, 18(8), 951-976. Abstract.  Author URL.
Green C (2009). Investigating public preferences on 'severity of health' as a relevant condition for setting healthcare priorities. Soc Sci Med, 68(12), 2247-2255. Abstract.  Author URL.
Thompson Coon JS, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, Stein K (2009). Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer, 101(2), 238-243. Abstract.  Author URL.  Full text.

2008

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectivemess of different inhaled corticosteroids and their usage with long-acting Beta-agonists for the treatment of chronic asthma in adults and children agerd 12 years and over. Health Technology Assessment, 12(9). Full text.
Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, et al (2008). Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technol Assess, 12(20), 1-iv. Abstract.  Author URL.  Full text.

2007

Hanney S, Buxton M, Green C, Coulson D, Raftery J (2007). An assessment of the impact of the NHS Health Technology Assessment Programme. Health Technol Assess, 11(53), iii-180. Abstract.  Author URL.  Full text.
Green C, Main C, Shepherd J, Anderson A (2007). Inhaled corticosteroids and long-acting beta2-agonists for the treatment of chronic asthma in children under the age of 12 years: Systematic review and economic analysis. Health Technology Assessment
Green C (2007). Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis. Pharmacoeconomics, 25(9), 735-750. Abstract.  Author URL.
Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS (2007). The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess, 11(21), iii-93. Abstract.  Author URL.  Full text.

2006

Kirby J, Green C, Loveman E, Clegg A, Picot J, Takeda A, Payne E (2006). A systematic review of the clinical and cost-effectiveness of memantine in patients with moderately severe to severe Alzheimer's disease. Drugs Aging, 23(3), 227-240. Abstract.  Author URL.
Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C (2006). A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease. Int J Geriatr Psychiatry, 21(1), 17-28. Abstract.  Author URL.
Green C, Dinnes J, Takeda AL, Cuthbertson BH (2006). Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Int J Technol Assess Health Care, 22(1), 90-100. Abstract.  Author URL.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2006). Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease - the authors' reply. PHARMACOECONOMICS, 24(6), 625-626. Author URL.
Green C (2006). Pharmacoeconomic Studies in Alzheimer's Disease. In Ritchie CW, Ames DJ, Masters CL, Cummings J (Eds.) Treatment Strategies in Alzheimer's Disease and other Dementias, Oxford: Clinical Publishing.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2006). The authors' reply [2]. PharmacoEconomics, 24(6), 625-626.

2005

Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, Cave C, Payne E, Cuthbertson BH (2005). Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. Health Technol Assess, 9(11), 1-iv. Abstract.  Author URL.
Green C, Picot J, Loveman E, Takeda A, Kirby J, Clegg A (2005). Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease. Pharmacoeconomics, 23(12), 1271-1282. Abstract.  Author URL.
Green C, Colquitt JL, Kirby J, Davidson P (2005). Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol, 152(1), 130-141. Abstract.  Author URL.

2004

Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N (2004). Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess, 8(43), iii-171. Abstract.  Author URL.
Green C, Colquitt JL, Kirby J, Davidson P, Payne E (2004). Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. Health Technol Assess, 8(47), iii-120. Abstract.  Author URL.

2003

Brazier J, Green C, McCabe C, Stevens K (2003). A review of VAS in economic evaluation. Journal of Pharmacoeconomics and Outcomes Research, 3(3), 293-302.
Green C, Kiebert G, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN (2003). Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Qual Life Res, 12(5), 565-574. Abstract.  Author URL.
Grieve R, Hutton J, Green C (2003). Selecting methods for the prediction of future events in cost-effectiveness models: a decision-framework and example from the cardiovascular field. Health Policy, 64(3), 311-324. Abstract.  Author URL.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 7(22), iii, 1-190.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 7(22). Abstract.
Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N (2003). The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. Health Technol Assess, 7(22), iii-190. Abstract.  Author URL.
Brazier J, Green C, McCabe C, Stevens K (2003). Use of visual analog scales in economic evaluation. Expert Review of Pharmacoeconomics and Outcomes Research, 3(3), 293-302. Abstract.

2002

Brazier JE, Green C, Kanis JA, Committee of Scientific Advisors International Osteoporosis Foundation (2002). A systematic review of health state utility values for osteoporosis-related conditions. Osteoporos Int, 13(10), 768-776. Abstract.  Author URL.

2001

Field D, Draper ES, Gompels MJ, Green C (2001). Measuring later health status of high risk infants: randomised comparison of two simple methods of data collection. BMJ, 323(7324), 1276-1280.
Green C (2001). On the societal value of health care: what do we know about the person trade-off technique?. Health Econ, 10(3), 233-243. Abstract.  Author URL.
Kiebert GM, Green C, Murphy C, Mitchell JD, O'Brien M, Burrell A, Leigh PN (2001). Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci, 191(1-2), 87-93. Abstract.  Author URL.
Deverill M, Brazier JE, Green C (2001). The use of health status measures in economic evaluation. In Stevens A, Abrams K, Brazier J (Eds.) The Advanced Handbook of Methods in Evidence Based Healthcare, London: SAGE.

2000

Akehurst R, Anderson P, Brazier J, Brennan A, Briggs A, Buxton M, Cairns J, Calvert N, Claxton K, Dixon S, et al (2000). Decision analytic modelling in the economic evaluation of health technologies - a consensus statement.  Author URL.
Green C, Brazier J, Deverill M (2000). Valuing health-related quality of life. A review of health state valuation techniques. Pharmacoeconomics, 17(2), 151-165. Abstract.  Author URL.

1999

Brazier J, Deverill M, Green C (1999). A review of the use of health status measures in economic evaluation. J Health Serv Res Policy, 4(3), 174-184. Abstract.  Author URL.
Dixon S, Green C (1999). Measuring outcomes in economic evaluations. This economics note is misleading. BMJ, 319(7211). Author URL.

1998

Green C, Akehurst R (1998). New therapeutic products and difficult decisions. The case of recombinant factor VIII in the management of haemophilia A. J Public Health Med, 20(2), 137-138. Abstract.  Author URL.
Deverill M, Brazier J, Green C, Booth A (1998). The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art. Pharmacoeconomics, 13(4), 411-420. Abstract.  Author URL.
Dolan P, Green C (1998). Using the PTO method to examine differences between individual and social values. Health Economics, 7(4), 307-312.

1997

Brazier J, Green C (1997). Economic evaluation in brief. In  (Ed) The Royal London Trauma Hospital: Trauma Care, London:.

Committee/panel activities

Multiple Sclerosis Society, GRP2 Panel Member

NIHR South-West Research for Patient Benefits (2007-2012)

NIHR Programme Grants for Applied Research (2008-2012)

Member of the Peninsula Health Technology Commissioning Group (PHTCG), supporting local CCGs. (2009-2013)


Editorial responsibilities

Academic Editor: PLoS ONE

Editorial Board Member: Applied Health Economics and Health Policy

Health Economics input to:

  • BMBS
  • BScMedSci
  • MSc Environment and Human Health
  • MSc Applied Health Service Research

Supervision of PhD Students

Back | Edit Profile